Responses of plasma bradykinin and the renin-angiotensin axis to furosemide in essential hypertension
Takeda, Y.; Miyamori, I.; Ikeda, M.; Koshida, H.; Yasuhara, S.; Nagai, K.; Morise, T.; Takimoto, H.; Takeda, R.
Nihon Jinzo Gakkai Shi 27(4): 525-531
1985
ISSN/ISBN: 0385-2385 PMID: 3897676 Document Number: 242548
Document emailed within 1 workday
Related Documents
Cugini, P.; Serdoz, R.; Manconi, R.; Mancini, A.; Meucci, T. 1978: Effects of furosemide on plasma renin and aldosterone in three subtypes of essential hypertension Bollettino della Societa Italiana di Biologia Sperimentale 54(2): 111-115Collart, F.; Staroukine, M.; Verniory, A. 1985: Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension Acta Cardiologica 40(3): 269-276
Fang, C.C.; Chen, Y.M.; Chu, T.S.; Hsieh, B.S. 1993: Correlation between renin responsiveness to furosemide and antihypertensive effect of captopril in patients with normal-renin essential hypertension Journal of the Formosan Medical Association 92(11): 937-941
Vetter, H.; Zumkley, H.; Glänzer, K.; Witassek, F.; Wollnik, S.; Vetter, W. 1980: Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives Schweizerische Medizinische Wochenschrift 110(50): 1938-1941
Kutkuhn, B.; Chlebowski, H.; Hollenbeck, M.; Grabensee, B. 1989: Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension Zeitschrift für Kardiologie 78(3): 204-210
Fernández-Llama, P.; Poch, E.; Oriola, J.; Botey, A.; de la Sierra, A.; Revert, L.; Rivera, F.; Darnell, A. 1999: Genetic polymorphisms of the renin-angiotensin system and essential hypertension Medicina Clinica 112(15): 561-564
Zofková, I. 1976: The effect of furosemide stimulation on renin secretion and its application in examining activity of the renin-angiotensin system Cor et Vasa 18(4): 304-309
Posadas, C.; Sánchez Torres, G.; Morales, M.; Rangel, J.; Cuéllar, A.; Serrano, P.A. 1977: Arterial damage and the renin-angiotensin system in essential hypertension. Study of 63 cases Archivos del Instituto de Cardiologia de Mexico 47(6): 663-672
Memezawa, H.; Abe, K.; Irokawa, N.; Chiba, H.; Yasujima, M. 1975: Sodium metabolism in essential hypertension. Renin subgroups and changes of urinary sodium excretion caused by furosemide Nihon Jinzo Gakkai Shi 17(2): 63-68
De Ferrari, G.; Gaiter, A.; Ginevri, F.; Tizianello, A. 1979: Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency La Clinica Terapeutica 90(5): 461-468
Irokawa, N.; Abe, K.; Aoyagi, H.; Memezawa, H.; Yasujima, M. 1973: Plasma renin activity in essential hypertension Nihon Jinzo Gakkai Shi 15(11): 949-960
García Zozaya, J.L.; Padilla Viloria, M. 1997: Alterations of calcium, magnesium, and zinc in essential hypertension:their relation to the renin-angiotensin-aldosterone system Investigacion Clinica 38(Suppl 2): 27-40
Milicević, Z.; Jelaković, B.; Marinković, M. 1994: Hyperuricemia and plasma renin activity in essential arterial hypertension Lijecnicki Vjesnik 116(1-2): 14-17
Gordon, R.D.; Gomez-Sanchez, C.E.; Hamlet, S.M.; Tunny, T.J.; Klemm, S.A. 1987: Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 5(5): S103-S106
Cerasola, G.; Cottone, S.; Mangano, M.T.; D'Ignoto, G.; Pinto, A.; Carone, M.B. 1988: Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension Clinical Therapeutics 10(6): 694-703
Nowicki, M.; Kokot, F.; Wiecek, A. 1993: Relation between erythropoietin production and plasma renin activity in patients with essential hypertension Kardiologia Polska 39(7): 17-22
Melina, D.; Guerrera, G.; Martino, G.; Salera, P.; Gattini, G.; Savi, L.; Cardillo, G. 1985: Evaluation of plasma renin activity as a cardiovascular risk factor in essential arterial hypertension Minerva Cardioangiologica 33(11): 717-723
Hornych, A.; London, G.; Safar, M.; Weiss, Y.; Simon, A.; Guyene, T.T.; Bariéty, J.; Milliez, P. 1978: Plasma prostaglandins and the renin-aldosterone system in patients with labile or permanent essential hypertension Journal d'Urologie et de Nephrologie 84(12): 843-849
Kucerová, V.; Peleska, J.; Linhartová, J.; Ort, J. 1977: Functional dependence of prostaglandin F2alpha concentration and plasma renin activity in essential hypertension Casopis Lekaru Ceskych 116(37): 1142-1148
Kimura, M.; Ishimaru, K. 1980: Studies on effects of renin-angiotensin system on hemodynamics and cardiovascular system in essential hypertension Nihon Jinzo Gakkai Shi 22(11): 1447-1462